Lee Leonard, President: Founder, CEO, Board Director

Lee Leonard is an accomplished CEO of start-up biotechnology firms having served in that capacity for three separate companies over the last 12 years. He co-founded Integrated Biosystems in 1996, led the company through two rounds of VC financing, drove a 25X increase in valuation and ultimately assisted in the sale of the company to Stedim S.A. (Now part of Sartorius Stedim Biotech). Following IBI, he joined an early-stage therapeutic antibody development company,  and led the company through 2 rounds of angel financing. Prior to his start-up experience, Lee held senior sales and marketing positions with renowned biotech firms including Millipore, Sepracor, Biosepara and Sepragen. He began his career in Process Science at Genentech, where he worked for 6 years. He holds a Bachelor of Science degree in Biochemistry from North Carolina State University.

Bernard Lemaître: Founder, Board Director

After earning his degree in Engineering, Mr. Lemaître began his career in sales and marketing in positions of increasing responsibility over a 15-year period with Sanofi-Aventis. He then co-founded Stedim SA, a pioneering company developing sterile single- use systems for the pharmaceutical and biotechnology industry. Stedim SA was merged with Sartorius AG. Mr. Lemaître serves as Board Director of Sartorius-Stedim Biotech.

John T. Chen Ph.D. : Board Director

Dr. Chen is a General Partner and co-founder of Phoenix Venture Partners (PVP). He brings over 20 years of experience in venture capital, start-ups, industry, and R&D. Prior to co-founding PVP, Dr. Chen was a Kauffman Fellow at Battery Ventures, where he formulated Battery’s Advanced Materials investment strategy, sourcing over 1,200 investment opportunities and managing several investments with applications in IT and CleanTech, e.g., Lion Cells, Stonybrook Purification and Nanoconduction (acquired). Dr. Chen started his venture capital career at DFJ New England and Navigator Technology Ventures in Boston. Prior to becoming a venture capitalist, Dr. Chen held leadership roles in business, technology, and product development at several startups and leading corporations in the Advanced Materials sector, including Luminus Devices, EM Logix, Surface Logix, and Raychem (acquired). He also led Advanced Materials technology scouting and business development in the areas of energy storage, fuel cells, photonics, and, more broadly, nanotechnology, at Tyco Electronics in the Advanced Technology and Business Development Group following Tyco’s acquisition of Raychem. Dr. Chen earned his BS, MBA, and PhD from MIT. In addition to his investment and board roles with PVP, Dr. Chen serves on the Commercialization Advisory Board for Oregon Built Environment & Sustainability Technologies (BEST) and is an active mentor to several startups through the MIT Venture Mentoring Service.

Nobi Kambe, Ph.D. : Board Director

Dr. Kambe is a Partner and co-founder of Phoenix Venture Partners (PVP). He is a distinguished inventor and serial entrepreneur with deep expertise in nanomaterials. Dr. Kambe has over 50 issued patents and is the founder of three successful start-ups, Nanogram Devices (acquired), Neophotonics (IPO), and Nanogram Corporation (acquired). Earlier in his career, Dr. Kambe was a Research Manager in semiconductor and carbon nanomaterials and devices at Nippon Telegraph & Telephone (NTT) where he became Senior Manager of New Business Strategy in Strategic Planning, with oversight responsibilities for thousands of patetns and hundreds of commercialization and R&D partnerships. Dr. Kambe was also a Managing Director at the International Center for Materials Research (ICMR) in Japan and was the founder of ICMR-USA. Dr. Kambe earned his BS and MS from Keio University and his PhD from MIT. He is a frequent lecturer at the University of Tokyo, Kagawa University, and Keio University, and has been a member of the Evaluation Committee for Nanotechnology at AIST, a major national laboratory in Japan.

Christopher van Ingen: Board Director

Mr. Van Ingen joined Senova Systems, Inc. as a Director in November 2011. Mr. van Ingen currently serves as Chairman of Bruker EST, Inc., a provider of superconducting-based materials and devices; Chairman of Accelrys, Inc., a provider of scientific informatics solutions for the Life Sciences & Applied markets; and Director of Promega Corporation; a provider of Life Sciences reagents and system solutions. In addition, Mr. van Ingen also serves as a strategic consultant to several companies in the Life Sciences and Chemical Analysis instrumentation industry.  Prior to his, Mr. van Ingen was President of Agilent Technologies’ Bio-Analytical Measurement business from 2001-2007, and held several other senior management positions at Agilent Technologies and the Hewlett Packard Company prior to 2001.

Misti Ushio, PhD: Board Observer

Misti is a Managing Director at Harris & Harris Group.  Prior to joining Harris & Harris Group in 2007, Misti worked at Merck & Co. for over 10 years in BioProcess Research & Development focused on vaccines and biologics, and was a Technology Licensing Officer at Columbia University.

Misti currently serves on the board of Ancora Pharmaceuticals Inc. and OpGen, Inc.  She is involved with Ensemble Therapeutics Corporation,  Mersana Therapeutics, Inc. and Champions Oncology, Inc. and was previously involved with BioVex, Inc. (acquired by Amgen).

She was graduated from Johns Hopkins University (B.S., Chemical Engineering), Lehigh University (M.S., Chemical Engineering) and University College London (Ph.D., Biochemical Engineering).

Gil M. Labrucherie, J.D. : Secretary

Mr. Labrucherie is Senior Vice President, General Counsel and Secretary at Nektar Therapeutics, a biopharmaceutical company. Prior to joining Nektar, from October 2000 to September 2005, Mr. Labrucherie was Vice President of Corporate Development at E2open, Inc., where he was responsible for global corporate alliances and merger and acquisition activity. Previously, he was the Senior Director of Corporate Development at AltaVista Company, an Internet search company, where he was responsible for merger and acquisition transactions. Gilbert began his career as an associate in the corporate practice of the law firm of Wilson Sonsini Goodrich & Rosati and Graham & James (DLA Piper Rudnick). He received his Juris Doctorate from University of California Boalt Hall School of Law, where he was a member of the California Law Review and Order of the Coif, and received his Bachelor of Arts degree from the University of California Davis.